PREVAIL Team
pRINCIPAL INVESTIGATOR: Dr. rAVI rETNAKARAN
Dr. Ravi Retnakaran is an Endocrinologist at The Leadership Centre for Diabetes at Mount Sinai Hospital whose clinical research has focused on how to induce and maintain a remission in type 2 diabetes patients. In 2017 he was appointed the inaugural Boehringer Ingelheim Chair in Beta-Cell Preservation, Function and Regeneration.
Dr. Retnakaran is part of a diabetes research team at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health System, which ranks among the top in the world in diabetes research.
Investigator: Dr Caroline Kramer
Dr. Caroline Kramer is an Endocrinologist at The Leadership Centre for Diabetes at Mount Sinai Hospital whose clinical research has focused on new treatments for gestational diabetes and diabetes remission studies.
Investigator: Dr Bernard Zinman
Dr. Bernard Zinman is an Endocrinologist at The Leadership Centre for Diabetes at Mount Sinai Hospital whose research has focused on the prevention of the long-term complications of diabetes, new treatments for diabetes, and diabetes in high-risk populations.
research coordinator: emily fitzgerald
Emily Fitzgerald is a registered nurse and research coordinator at The Leadership Centre for Diabetes at Mount Sinai Hospital.
research coordinator: Alexandra Emery
Alexandra Emery is a registered nurse and research coordinator for the PREVAIL study at The Leadership Centre for Diabetes at Mount Sinai Hospital.